PER® Global Presents the 4th Annual European Congress on Immunotherapies in Cancer™ in Barcelona

This year’s program will be co-chaired by Antoni Ribas, M.D., Ph.D., professor of medicine, surgery and molecular and medical pharmacology, University of California, Los Angeles; director of the Tumor Immunology Program, Jonsson Comprehensive Cancer Center; and chair, Melanoma Committee, SWOG; and Caroline Robert, M.D., Ph.D., head of the dermatology unit, Gustave Roussy; co-director, melanoma research unit, INSERM 981, Paris-Sud University in France.

“We look forward to discussing one of the hottest areas in cancer research today at our 4th Annual European Congress on Immunotherapies in Cancer™ in Barcelona,” said Phil Talamo, president of PER^® Global^. “For this year’s congress, we have assembled a respected faculty and world-renowned keynote speakers who will provide insights into the use of immunotherapies in patient care.”

The European Congress on Immunotherapies in Cancer™ is a two-day comprehensive and interactive program intended for medical oncologists and other health care professionals whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies and emerging information on immunotherapies and their evolving roles in the treatment of cancer. During this congress, keynote speakers — James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D. — will be joined by international and national experts who will focus exclusively on immunotherapies and their practical application to the management of cancer. Additionally, the faculty will provide insight into recent clinical trials, scientific advances, proactive methods to monitor and mitigate treatment-related side events, current and emerging testing methods and multidisciplinary team approaches to optimize the use of immunotherapeutic strategies to treat cancer.

For more information and to register, click here.

About Physicians’ Education Resource^® (PER^®)

Since 1995, PER^® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER^® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside oncology, PER^® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER^® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER^® is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190718005706/en/